Finally, consistent with IL-37b being the most abundant isoform of IL-37, studies investigating tumor expression of the IL-37 splice variants identified IL-37b as the isoform expressed by breast, liver, lung and prostate cancer, with low levels of IL-37b significantly associated with poor prognosis (130). This evidence concerns the gene IL37 and prostate cancer.